课题基金 / 基金详情

Identification of Calcium integrin binding protein 1 (CIB1) competitor

Identification of Calcium integrin binding protein 1 (CIB1) competitor
钙整合素结合蛋白 1 (CIB1) 竞争对手的鉴定
批准号：
10011395
负责人：
Anton Simeonov
金额：
$13.27万
依托单位：
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/10011395
关键词：
Antiplatelet DrugsBinding ProteinsBiological AssayBlood PlateletsCalciumCalcium BindingCollaborationsCollectionDataExhibitsGrowthImpairmentIntegrin BindingIntegrinsMediatingMusPharmaceutical PreparationsSignal TransductionTestingThrombusValidationfollow-uphigh throughput screeningminiaturizepreventsmall molecule

项目摘要

项目成果

Anton Simeonov的其他基金

相似基金

相关文献

中文摘要
翻译
这项合作旨在发现能够阻止CIB1和IIb3结合的小分子，作为潜在的抗血小板药物。 在此期间，合作团队利用先前优化和小型化的CIB1检测对NCGC的几个小分子集合进行了定量高通量筛选。使用初步试验对识别的命中进行cherrypicked以进行初始验证，随后在后续试验中进行检测以提供额外的活性数据。
英文摘要
This collaboration seeks to uncover small molecules capable of preventing the association of CIB1 and IIb3 as potential anti-platelet agents. During this period, the collaborative team utilized the previously optimized and miniaturized CIB1 assay to conduct a quantitative high-throughput screen of several of NCGC's small molecule collections. Identified hits were cherrypicked for initial validation using the primary assay, and were subsequently tested in follow-up assays to provide additional activity data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRKACA for Fibrolamellar hepatocellular carcinoma
MST/ITC studies on Vimentin DHA interaction
Disrupting Type IV secretion function to prevent virulence in the pathogenic bacterium Legionella pneumophila
High-throughput multiparametric drug screening method for 3D spheroids
海外基金